vs
奥多比（ADBE）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
奥多比的季度营收约是费森尤斯医疗的1.2倍（$6.4B vs $5.5B），奥多比净利率更高（29.5% vs 7.9%，领先21.6%），奥多比同比增速更快（12.0% vs -0.3%）
奥多比（Adobe Inc.）前身为奥多比系统公司，是总部位于美国加利福尼亚州圣何塞的跨国计算机软件企业。旗下产品覆盖网页设计、图像处理、矢量创作、音视频编辑、移动应用开发、印刷排版、动画制作等多个领域，是全球领先的数字创意软件服务商。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
ADBE vs FMS — 直观对比
营收规模更大
ADBE
是对方的1.2倍
$5.5B
营收增速更快
ADBE
高出12.3%
-0.3%
净利率更高
ADBE
高出21.6%
7.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.4B | $5.5B |
| 净利润 | $1.9B | $434.2M |
| 毛利率 | 89.6% | 27.4% |
| 营业利润率 | 37.8% | 11.7% |
| 净利率 | 29.5% | 7.9% |
| 营收同比 | 12.0% | -0.3% |
| 净利润同比 | 4.3% | 240.4% |
| 每股收益（稀释后） | $4.60 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADBEFMS
| Q1 26 | $6.4B | — | ||
| Q4 25 | $6.2B | $5.5B | ||
| Q3 25 | $6.0B | — | ||
| Q2 25 | $5.9B | — | ||
| Q1 25 | $5.7B | — | ||
| Q4 24 | $5.6B | $5.5B | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $5.3B | — |
净利润ADBEFMS
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $434.2M | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.7B | $127.6M | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.6B | — |
毛利率ADBEFMS
| Q1 26 | 89.6% | — | ||
| Q4 25 | 89.5% | 27.4% | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 89.1% | — | ||
| Q1 25 | 89.1% | — | ||
| Q4 24 | 89.0% | 25.0% | ||
| Q3 24 | 89.8% | — | ||
| Q2 24 | 88.7% | — |
营业利润率ADBEFMS
| Q1 26 | 37.8% | — | ||
| Q4 25 | 36.5% | 11.7% | ||
| Q3 25 | 36.3% | — | ||
| Q2 25 | 35.9% | — | ||
| Q1 25 | 37.9% | — | ||
| Q4 24 | 34.9% | 5.1% | ||
| Q3 24 | 36.8% | — | ||
| Q2 24 | 35.5% | — |
净利率ADBEFMS
| Q1 26 | 29.5% | — | ||
| Q4 25 | 30.0% | 7.9% | ||
| Q3 25 | 29.6% | — | ||
| Q2 25 | 28.8% | — | ||
| Q1 25 | 31.7% | — | ||
| Q4 24 | 30.0% | 2.3% | ||
| Q3 24 | 31.1% | — | ||
| Q2 24 | 29.6% | — |
每股收益（稀释后）ADBEFMS
| Q1 26 | $4.60 | — | ||
| Q4 25 | $4.44 | — | ||
| Q3 25 | $4.18 | — | ||
| Q2 25 | $3.94 | — | ||
| Q1 25 | $4.14 | — | ||
| Q4 24 | $3.75 | — | ||
| Q3 24 | $3.76 | — | ||
| Q2 24 | $3.49 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.9B | $1.7B |
| 总债务越低越好 | $5.4B | — |
| 股东权益账面价值 | $11.4B | $15.4B |
| 总资产 | $29.7B | $33.5B |
| 负债/权益比越低杠杆越低 | 0.47× | — |
8季度趋势，按日历期对齐
现金及短期投资ADBEFMS
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.6B | $1.7B | ||
| Q3 25 | $5.9B | — | ||
| Q2 25 | $5.7B | — | ||
| Q1 25 | $7.4B | — | ||
| Q4 24 | $7.9B | $1.3B | ||
| Q3 24 | $7.5B | — | ||
| Q2 24 | $8.1B | — |
总债务ADBEFMS
| Q1 26 | $5.4B | — | ||
| Q4 25 | $6.2B | — | ||
| Q3 25 | $6.2B | — | ||
| Q2 25 | $6.2B | — | ||
| Q1 25 | $6.2B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.1B | — | ||
| Q2 24 | $4.1B | — |
股东权益ADBEFMS
| Q1 26 | $11.4B | — | ||
| Q4 25 | $11.6B | $15.4B | ||
| Q3 25 | $11.8B | — | ||
| Q2 25 | $11.4B | — | ||
| Q1 25 | $13.1B | — | ||
| Q4 24 | $14.1B | $17.0B | ||
| Q3 24 | $14.5B | — | ||
| Q2 24 | $14.8B | — |
总资产ADBEFMS
| Q1 26 | $29.7B | — | ||
| Q4 25 | $29.5B | $33.5B | ||
| Q3 25 | $28.8B | — | ||
| Q2 25 | $28.1B | — | ||
| Q1 25 | $30.0B | — | ||
| Q4 24 | $30.2B | $36.3B | ||
| Q3 24 | $29.8B | — | ||
| Q2 24 | $30.0B | — |
负债/权益比ADBEFMS
| Q1 26 | 0.47× | — | ||
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.28× | — | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0B | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $2.9B | — |
| 自由现金流率自由现金流/营收 | 45.7% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 1.57× | 6.67× |
| 过去12个月自由现金流最近4个季度 | $10.3B | — |
8季度趋势，按日历期对齐
经营现金流ADBEFMS
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.2B | $2.9B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $1.9B | — |
自由现金流ADBEFMS
| Q1 26 | $2.9B | — | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $1.9B | — |
自由现金流率ADBEFMS
| Q1 26 | 45.7% | — | ||
| Q4 25 | 50.5% | — | ||
| Q3 25 | 35.5% | — | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 43.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.3% | — | ||
| Q2 24 | 35.8% | — |
资本支出强度ADBEFMS
| Q1 26 | 0.6% | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 0.8% | — |
现金转化率ADBEFMS
| Q1 26 | 1.57× | — | ||
| Q4 25 | 1.70× | 6.67× | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.30× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | — | 20.20× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADBE
| Subscription Revenue | $6.2B | 97% |
| Service Other | $110.0M | 2% |
| Products | $90.0M | 1% |
FMS
暂无分部数据
